Introduction

Bronchogenic cysts (BCs) represent a spectrum of bronchopulmonary malformations that result from an abnormal budding of the tracheobronchial tree during fetal development [1,2,3]. They may be detected at any age. The cysts are usually solitary and thin-walled. Most BCs are located in the mediastinum, while an intrapulmonary localization is also possible. BCs in the mediastinum, are most frequently located in the pericarinal area followed by the right trachea and hilum; whereas intrapulmonary BCs are commonly localized in the lower lobes [4,5,6]. The cysts contain bronchial cartilage, smooth muscle, elastic tissue, and mucous glands. Histopathologically, the internal cystic wall is covered with a ciliary columnar or cuboidal epithelium [7, 8]. BCs exhibit a variety of clinical and radiologic presentations, posing a diagnostic challenge, especially in areas with endemic hydatid disease. Endoscopic drainage has emerged as a diagnostic and potentially therapeutic option [9]. BCs may be symptomatic or asymptomatic. The symptoms vary depending on the location and adjacent structures, as they can cause infection and other complications such as compression of the tracheobronchial tree leading to stridor, bronchospasms, respiratory distress, or air trapping [5, 10]. BCs are rarely detected during prenatal sonography, and Computed Tomography (CT) is highly useful in diagnosis. In suspected cases, Magnetic Resonance Imaging (MRI) provides additional information in differentiating cystic from solid lesions. Barium studies can also be helpful to show the abnormal relation between the respiratory tract and esophagus or stomach. On differential diagnosis, esophageal duplication cysts, neuroenteric cysts, congenital pulmonary adenoid malformation (CPAM) and cystic teratoma, or thymic cyst should be kept in mind as differntials [4, 5]. The management of patients with uncomplicated bronchogenic cysts has evolved over the last decade with the development of more precise diagnostic techniques and a better understanding of the variable natural history of these lesions. Although a surgical approach is still indicated for infants and children, there is disagreement with this invasive approach [11]. Minimally invasive surgical methods, such as thoracoscopy [12], mediastinoscopy [13], percutaneous drainage approach [14] and endobronchial ultrasound-transbronchial needle aspiration for carinal or paratracheal cysts have been safely used to manage these lesions [15]. An air-fluid level in the cyst, the rare presence of malignant cells in the aspirate or biopsy, or enlargement or recurrence of the cyst on follow-up examination mandates complete surgical removal [16,17,18,19].

Patient report

A 6-month-old male infant with severe recurrent respiratory distress had multiple admissions to the Pediatric Intensive Care Unit. Clinical exam revealed diminished breath sounds over the right chest, and bilateral, moist rales and wheezing. The initial chest x-ray showed a hyperaerated right lung and a mediastinal shift to the left. A diagnosis of bronchiolitis was suspected, and the patient was managed accordingly. However, subsequent x-rays continued to show overdistension of the right lung. CT of the chest revealed a mediastinal mass with fluid density, located within the sub-carinal area (Fig. 1b). The clinical suspicion now moved to foreign body aspiration or tracheo-esophageal fistula, especially due to recurrent respiratory infections, respiratory distress during breastfeeding, and resultant hyperinflation of the right lung. A rigid bronchoscopy under general anesthesia was performed and a dome-shaped carina with obliteration of the sharp angle and significant external non-pulsatile compression on both entrance of the main bronchi, especially the right side, were noticed (Fig. 1a). A fine needle aspiration (Fig. 2a)was performed under direct visualization removing 6 ml of fluid after which the protruding impression of the lesion regressed. A holmium laser (Fig. 2b) was used to create a window at the site of the puncture (Fig. 1c). The cystic cavity was then enetred by the bronchoscope that confirmed the integrity of the cystic wall. The infant improved after the procedure and was discharged after 3 days. Follow up for 10 months has shown complete recovery from respiratory symptoms, except an occurrence of intussusception in the ninth month of follow-up.

Fig. 1
figure 1

A Bronchoscopy reveals dome-shaped carina with sharp obliteration of both main bronchi. B Chest CT reveals a mediastinal mass with fluid density, located within the sub-carinal area. C Bronchoscopic view of the anterior surface of cyst after fenestration

Fig. 2
figure 2

A Bronchoscopic view showing the needle aspiration of cyst. B View at the commencement of cyst fenetsration by laser

Discussion

BCs are frequently incidental findings on ultrasound or chest radiograph in the neonatal period [20]. Symptoms in neonates are usually related to mass effect on the involved structure or infection [21]. Major bronchus obstruction is rare but has been reported in the setting of a sub-carinal cyst [22]. More commonly, the presentation mimics centrilobular emphysema secondary to air trapping of the smaller airways [23].

A retrospective 20 years report from a tertiary pediatric center on 45 BCs pointed out that 82.2% BCs were located in sub-carinal and paratracheal area (Group I), and the rest in Group II with intrapulmonary presentation. In Group I, a partial resection was done because of adherence to the airway, and the majority of these (90%) were approached by thoracoscopy. while Group II, a lobectomy was done. Complications occurred in seven patients (15%): subcutaneous emphysema, extubation failure, reoperation due to bleeding, surgical site infection, bronchopleural fistula, and pneumothorax [9].

Maturu et al. reported the role and safety of endobronchial ultrasound-guided transbronchial needle aspiration [24]. Complete surgical excision on the other hand ensures a decreased chance of recurrence and eliminates the theoretical risk of malignancy, as the wall of the cyst is removed [16]. Most of the cysts are in the mediastinum and require at least VATS for complete removal, if not thoracotomy [26]. These procedures are major operations, with the latter approach more associated with significant mortality and morbidity [25]. There are multiple reports of recurrence after surgery especially if complete excision is not performed [27,28,29]. The risk and benefit of this approach needs to be discussed with the patient's family. If complete excision is not possible, surgical approach is probably not justified since BCs have been reported to recur in these instances [27,28,29]. In addition, incomplete resections do not eliminate the theoretical risk of malignancy and offers no advantage in our opinion over the less invasive bronchoscopic approach. The use of sclerosing agent is rare in the literature and should be attempted if recurrence occurs and patient is not a surgical candidate [27]. Our procedure also offers a solution for difficult-to-manage intraluminal cases, an example of which is a published case that required thoracoscopic surgery that resulted in a recurrence, later requiring open surgery with removal of some parts of the trachea [30]. There is no known optimal duration of follow-up, and because of presence of multiple reports of recurrence and rare risk of malignancy, there is need for extended follow-up. Follow up should probably be continued for at least 36 months since there are currently no reports that suggest recurrence can occur after this time [31,32,33].

Conclusion

The optimal strategy for management of mediastinal BCs remains unknown. Bronchoscopic laser fenestration is a safe option and can be both diagnostic and therapeutic for the management of paratracheal and sub-carinal BCs. This technique initially cannot be an alternative for surgical excision, because of microspillage of cystic content triggers strong inflammatory reaction and hence the experts opinion is to removing BCs completely. So this technique at least should be reserved for hemodynamically unstable children who cannot tolerate a thoracotomy or thoracoscopy. If this technique is used an extended follow-up for at least 36 months is recommended.